Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 28, 2024
Dec. 30, 2023
Current Assets    
Cash and cash equivalents $ 102.1 $ 171.7
Accounts receivable, less allowance for credit losses of $11.9 and $3.6, as of September 28, 2024 and December 30, 2023, respectively 160.8 174.1
Contract assets 25.3 49.7
Inventories 54.5 48.4
Prepaid expenses 9.0 8.4
Other current assets 23.6 10.8
Total current assets 375.3 463.1
Property, plant and equipment, net 58.4 52.4
Right-of-use assets, net 51.1 50.9
Intangible assets, net 392.0 375.3
Goodwill 383.9 368.6
Deferred tax assets, net 28.9 36.8
Other assets 5.4 2.9
Total assets 1,295.0 1,350.0
Current Liabilities    
Accounts payable 52.1 59.8
Contract liabilities 21.1 26.7
Current maturities of long-term debt 7.3 7.3
Accrued expenses and other current liabilities 53.7 80.3
Total current liabilities 134.2 174.1
Long-term debt, net 586.1 607.7
Deferred tax liabilities, net 1.8 1.7
Other long-term liabilities 46.3 46.9
Total liabilities 768.4 830.4
STOCKHOLDERS’ EQUITY    
Common stock, 825,000,000 shares authorized, $0.0001 par value, 147,234,872 and 146,861,489 shares issued as of September 28, 2024 and December 30, 2023, respectively 0.0 0.0
Treasury stock, at cost, 6,160,579 and 34,297 shares as of September 28, 2024 and December 30, 2023, respectively (72.5) (0.4)
Additional paid-in capital 296.2 289.0
Accumulated other comprehensive loss (1.1) (2.9)
Retained earnings 304.0 233.9
Total stockholders’ equity 526.6 519.6
Total liabilities and stockholders’ equity $ 1,295.0 $ 1,350.0